Skip to content
Disclosery

13F-HR filed by Catalio Capital Management, LP

Catalio Capital Management, LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 33 holding rows worth $457,135,528.

Accession
0001958125-25-000002
Filer
CIK 1958125
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 33 entries on the cover page, a total value of $457,135,528 stated on the cover page (in dollars after the unit check, H1), rows summing to $457,135,528 with VALUE read as dollars as filed, 13F file number 028-25237. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BECTON DICKINSON & CO075887109COM148,615$33,716,285dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR215,587$29,679,862dollars as filed
Bristol-Myers Squibb Company110122108COM499,151$28,231,981dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM764,668$27,627,455dollars as filed
BLUEPRINT MEDICINES CORP09627Y109COM284,654$24,827,522dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock333,144$24,662,650dollars as filed
BRIDGEBIO PHARMA INC10806X102COM898,458$24,653,688dollars as filed
LIVANOVA PLCG5509L101SHS512,447$23,731,421dollars as filed
SEPTERNA INC COM81734D104Stock1,024,245$23,455,211dollars as filed
CYTOKINETICS INC23282W605COM NEW457,587$21,524,892dollars as filed
ENVISTA HOLDINGS CORPORATION29415F104COM1,019,529$19,666,714dollars as filed
VERACYTE INC COM92337F107Stock490,547$19,425,661dollars as filed
Intuitive Surgical,Inc.46120E602COM36,910$19,265,544dollars as filed
EXACT SCIENCES CORP COM30063P105Stock309,103$17,368,498dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM763,471$16,643,668dollars as filed
UNIQURE NVN90064101SHS901,973$15,928,843dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY569,395$15,441,992dollars as filed
MASIMO CORP COM574795100Stock87,377$14,443,418dollars as filed
DISC MEDICINE INC COM254604101Stock179,815$11,400,271dollars as filed
ADMA BIOLOGICS INC000899104COM512,724$8,793,217dollars as filed
INARI MED INC45332Y109COM132,545$6,766,422dollars as filed
Boston Scientific Corporation101137107COM72,925$6,513,661dollars as filed
KEROS THERAPEUTICS INC COM492327101Stock407,292$6,447,432dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK1,088,691$5,748,288dollars as filed
Mersana Therapeutics Inc59045L106Common Stock1,705,036$2,438,201dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK586,909$2,195,040dollars as filed
METAGENOMI THERAPEUTICS INC59102M104COM528,993$1,909,665dollars as filed
KARYOPHARM THERAPEUTICS INC48576U106COM2,334,375$1,578,738dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock187,184$1,533,037dollars as filed
HYPERFINE INC44916K106Common Stock760,035$668,831dollars as filed
FRACTYL HEALTH INC35168W103COM214,236$441,326dollars as filed
ATAIBECKLEY INCN0731H103Equity196,858$261,821dollars as filed
SENSEI BIOTHERAPEUTICS INC81728A108COM294,374$144,273dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001958125-25-000002this filing2025-02-14acceptance time not in the bulk data set